Media Contact:
Julie Cohen
Director of Marketing and Communications
Phone: 212.701.3614
Fax: 212.378.2410
jcohen@cahill.com

Firm News

Valeant Pharmaceuticals Completes Bond Offering

Date: 02/08/11

Cahill represented the initial purchasers in a Rule 144A/Reg S Offering of $650 million of 6.750% Senior Notes due 2021 by Valeant Pharmaceuticals International. Valeant intends to use the net proceeds from the offering of the Notes to finance acquisitions and for general corporate purposes.

Media Contact:
Julie Cohen
Director of Marketing and Communications
Phone: 212.701.3614
Fax: 212.378.2410
jcohen@cahill.com